MediWound: After 12 Months of Follow-Up, NexoBrid’s Safety, Cosmesis and Function Data in the U.S. Phase 3 Trial (DETECT) are comparable to Standard of Care – CBI
Homepage/Press Release/MediWound: After 12 Months of Follow-Up, NexoBrid’s Safety, Cosmesis and Function Data in the U.S. Phase 3 Trial (DETECT) are comparable to Standard of Care
Press Release
MediWound: After 12 Months of Follow-Up, NexoBrid’s Safety, Cosmesis and Function Data in the U.S. Phase 3 Trial (DETECT) are comparable to Standard of Care
